Karen Colwill

8.7k citations

55 papers · 2.9k indexed · h-index 22

Impact in

Cell Biology top 2%
- Cellular transport and secretion
- Hippo pathway signaling and YAP/TAZ
Molecular Biology top 5%
- RNA Research and Splicing
- RNA and protein synthesis mechanisms
- RNA modifications and cancer
- Protein Kinase Regulation and GTPase Signaling

Papers in

Infectious Diseases 23
- SARS-CoV-2 and COVID-19 Research 21
- COVID-19 Clinical Research Studies 18
- SARS-CoV-2 detection and testing 11
Modeling and Simulation 5
- COVID-19 epidemiological studies 5

Co-authors: Tony Pawson James L. Manley Brenda Andrews S. Gräslund Peter I. Duncan John C. Bell J.K. Prasad Adrian Pasculescu
Journals: Microbiology Spectrum (5 papers)Molecular and Cellular Biology (4 papers)PLoS ONE (3 papers)Transfusion (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: Canada United States Sweden

In The Last Decade

Karen Colwill

48 papers receiving 2.9k citations

Peers

Countries citing papers authored by Karen Colwill

Since Specialization

Citations

This map shows the geographic impact of Karen Colwill's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Karen Colwill with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Karen Colwill more than expected).

Fields of papers citing papers by Karen Colwill

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Karen Colwill. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Karen Colwill. The network helps show where Karen Colwill may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Karen Colwill, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Karen Colwill Line = papers co-authored together Karen Colwill links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Immunogenicity of COVID-19 booster vaccines in children receiving immunosuppressive medications Pediatric Research ·Janna R. Shapiro, Fiona Choi, Amy Xu, Trang T. Duong, Anne‐Claude Gingras, Karen Colwill, Sasha Bernatsky, Susanne M. Benseler, Rae S. M. Yeung, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2025	0
2	Humoral Response Following 3 Doses of mRNA COVID-19 Vaccines in Patients With Non-Dialysis-Dependent CKD: An Observational Study Canadian Journal of Kidney Health and Disease ·Èlia Turon Marimon, Kevin Yau, Lee Er, Mohammad Atiquzzaman, Matthew J. Oliver, Marc G. Romney, Jerome A. Leis, Kento T. Abe, Cairo Molina Arauz, Karen Colwill, Anne‐Claude Gingras, Michelle Hladunewich, Adeera Levin	2024	0
3	Seroprevalence of SARS-CoV-2 antibodies among children receiving primary care in Toronto, Ontario Canadian Journal of Public Health ·Mary Aglipay, Jeffrey C. Kwong, Karen Colwill, Byong Cheol Choi, Ashleigh R. Tuite, Muhammad Mamdani, Charles Keown‐Stoneman, Catherine S. Birken, Jonathon L. Maguire, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	2024	0
4	Enhancing detection of SARS-CoV-2 re-infections using longitudinal sero-monitoring: demonstration of a methodology in a cohort of people experiencing homelessness in Toronto, Canada BMC Infectious Diseases ·Lucie Richard, Rosane Nisenbaum, Karen Colwill, Sharmistha Mishra, Roya M. Dayam, Michael Liu, Cheryl Pedersen, Anne‐Claude Gingras, Stephen W. Hwang	2024	4
5	Two‐phase Bayesian latent class analysis to assess diagnostic test performance in the absence of a gold standard: COVID‐19 serological assays as a proof of concept Vox Sanguinis ·S Stankowski, June Dubé, Chelsea Caya, Matthew P. Cheng, Karen Colwill, Rachel Corsini, Anne‐Claude Gingras, Agatha N. Jassem, Mel Krajden, Ana Márquez, Bruce Mazer, Andrew K Goodenough, Christian Renaud, Cédric P. Yansouni, Jesse Papenburg, Antoine Lewin	2023	2
6	Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021 Microbiology Spectrum ·Yi-Chan Lin, David H. Evans, A. John Joel, V.S. Ilyushechkin, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne‐Claude Gingras, Ashleigh R. Tuite, Qilong Yi, Sheila F. O’Brien, Steven J. Drews	2023	0
7	COVID-19 vaccine antibody responses in community-dwelling adults to 48 weeks post primary vaccine series iScience ·Sharon Walmsley, Leah Szadkowski, Bradly G. Wouters, Olaf Ullrich, Karen Colwill, Paula A. Rochon, Michael Brudno, Parveen K. Garg, Janet Raboud, Allison McGeer, Amit M. Oza, Christopher J Graham, Amanda Silva, Dorin Manase, Gianmarco Gemini, Siwei She, Jun He, W. J. Craig, Adrian Pasculescu, Anne‐Claude Gingras	2023	4
8	Predictors of Breakthrough SARS-CoV-2 Infection after Vaccination Vaccines ·Sharon Walmsley, Gua-Hai Wu, Leif E. Lovblom, Gertraud Schorer-Mörtel, Karen Colwill, Allison McGeer, Z. Y. Li, Dorin Manase, Anne‐Claude Gingras, (unknown)	2023	4
9	Omicron variant neutralizing antibodies following BNT162b2 BA.4/5 versus mRNA-1273 BA.1 bivalent vaccination in patients with end-stage kidney disease Nature Communications ·Kevin Yau, Zhengxuan Bao, Cairo Molina Arauz, R. Specty, Л. Романкова, Queenie Hu, 鈴木榮一, Ren Ke, Èlia Turon Marimon, Adeera Levin, Weihan Cai, W. Rod Hardy, Darren A. Yuen, Jeffrey Perl, Christopher T. Chan, Jerome A. Leis, Matthew J. Oliver, Karen Colwill, Anne‐Claude Gingras, Michelle Hladunewich	2023	5
10	Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses Microbiology Spectrum ·Yi-Chan Lin, David H. Evans, Loreta Tamošaitienė, V.S. Ilyushechkin, Queenie Hu, Reuben Samson, Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne‐Claude Gingras, Ashleigh R. Tuite, Qilong Yi, Sheila F. O’Brien, Steven J. Drews	2022	7
11	Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) seroprevalence: Navigating the absence of a gold standard PLoS ONE ·Sahar Saeed, Sheila F. O’Brien, Kento T. Abe, Qilong Yi, Bhavisha Rathod, Jenny Wang, Mahya Fazel‐Zarandi, Ashleigh R. Tuite, David N. Fisman, Heidi Wood, Karen Colwill, Anne‐Claude Gingras, Steven J. Drews	2021	12
12	MERTK Interactions with SH2-Domain Proteins in the Retinal Pigment Epithelium PLoS ONE ·和久荒木, Karen Colwill, Sirano Dhe‐Paganon, Tony Pawson, Debra A. Thompson	2013	21
13	Temporal regulation of EGF signalling networks by the scaffold protein Shc1 Nature ·Yong Zheng, Cunjie Zhang, David R. Croucher, Mohamed A. Soliman, Nicole St‐Denis, Adrian Pasculescu, Lorne Taylor, Stephen Tate, W. Rod Hardy, Karen Colwill, A.A. Dikova, Richard D. Bagshaw, James W. Dennis, Anne‐Claude Gingras, Roger J. Daly, Tony Pawson	2013	223
14	A roadmap to generate renewable protein binders to the human proteome Nature Methods ·(unknown), Karen Colwill, S. Gräslund	2011	261
15	Generating a panel of highly specific antibodies to 20 human SH2 domains by phage display Protein Engineering Design and Selection ·Н. Н. Редькина, Anne-Marie Bessette, S. Gräslund, Peter Nilsson, Karen Colwill, Aneesh Karatt-Vellatt, Darren J. Schofield, Michael R. Dyson, Tony Pawson, Brian K. Kay, John McCafferty	2010	46
16	NOS1AP Associates with Scribble and Regulates Dendritic Spine Development Journal of Neuroscience ·Yanling Zhao, Grupo de Educación Para la Salud de la AEPap, Xuegui Kan, Karen Colwill, Michael J. O’Brien, Christopher W. Tsang, K H Mazalan, Francy Penna Cuellar, Pavel Metalnikov, William S. Trimble, Stefan Krueger, Tony Pawson, J. Paul Fawcett	2010	59
17	Characterization of the Yeast Amphiphysins Rvs161p and Rvs167p Reveals Roles for the Rvs Heterodimer In Vivo Molecular Biology of the Cell ·Helena Friesen, Ngarukiyimana Jean Paul, Yuen Ho, B. Metzger, Karen Colwill, Brenda Andrews	2006	48
18	The Protein Kinase Clk/Sty Directly Modulates SR Protein Activity: Both Hyper- and Hypophosphorylation Inhibit Splicing Molecular and Cellular Biology ·Jayendra Prasad, Karen Colwill, Tony Pawson, James L. Manley	1999	179
19	Interaction of yeast Rvs167 and Pho85 cyclin-dependent kinase complexes may link the cell cycle to the actin cytoskeleton Current Biology ·Jinhwa Lee, Karen Colwill, Mercy Nnyigide Nkoli, Nasrin Sudmand, Lynda Moore, Yuen Ho, Brenda Andrews	1998	72
20	RS cyclophilins: Identification of an NK-TR1-related cyclophilin Gene ·Frederick P. Nestel, Karen Colwill, Brady Hicks, Tony Pawson, Stephen K. Anderson	1996	42

About Karen Colwill

Karen Colwill is a scholar working on Infectious Diseases, Modeling and Simulation, Obstetrics and Gynecology, Aging and Health, having authored 55 papers that have together received 2.9k indexed citations. Recurring topics across this work include SARS-CoV-2 and COVID-19 Research (21 papers), COVID-19 Clinical Research Studies (18 papers), SARS-CoV-2 detection and testing (11 papers), COVID-19 Impact on Reproduction (5 papers), COVID-19 epidemiological studies (5 papers), Fungal and yeast genetics research (5 papers), Vaccine Coverage and Hesitancy (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cell Biology (572 citations), Molecular Biology (2.3k citations), Virology (100 citations), Immunology and Allergy (83 citations) and Spectroscopy (210 citations). Karen Colwill has collaborated with scholars based in Canada, United States and Sweden. Frequent co-authors include Tony Pawson, James L. Manley, Brenda Andrews, S. Gräslund, Peter I. Duncan, John C. Bell, J.K. Prasad, Adrian Pasculescu, Gerald Gish and Jayendra Prasad. Their work appears in journals such as Microbiology Spectrum, Molecular and Cellular Biology, PLoS ONE, Transfusion and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact